financetom
Business
financetom
/
Business
/
Snoop Dogg helps Publicis claim world's largest ad group title
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Snoop Dogg helps Publicis claim world's largest ad group title
Dec 4, 2024 5:32 AM

LONDON, Dec 4 (Reuters) - France's Publicis

has enlisted Snoop Dogg, the American rapper who became a

breakout star at the Paris Olympics, to help it celebrate

overtaking British rival WPP ( WPP ) as the world's largest ad

group in 2024.

Snoop Dogg was seen everywhere at the Olympics, from

carrying the torch to dressing in riding gear at equestrian

events and cheering on gymnasts and athletes, in his role as a

special correspondent for U.S. network NBC.

Appearing with the rapper in the group's annual "The Wishes"

video message, Chairman and Chief Executive Arthur Sadoun said

"Mister Snoop" took over Paris in the summer and he was now

helping "our little French holding company, Publicis, get ready

for 2025".

"That's right - what's Publicis holding? I don't know - but

what I do know is that Americans, Brits and French have been

competing to see which holding company is the top dog," Snoop

Dogg said in the video. "And this year, Publicis has overtaken

them all. Les Numeros One."

Publicis has gained market share this year in contrast to

peers facing sluggish growth.

The parent of agencies Leo Burnett and Saatchi & Saatchi has

been growing faster than the other three major holding groups -

WPP ( WPP ), Interpublic and Omnicom ( OMC ) - helped by

the targeted ad capabilities of its Epsilon Unit, powered by a

huge amount of consumer behaviour data.

For the first nine months of 2024, Publicis reported net

revenue of 10.11 billion euros.

WPP ( WPP ), for decades the world's number one, reported equivalent

revenue less pass-through costs of 8.36 billion pounds or 10.08

billion euros.

Analysts expect Publicis to come in at 13.9 billion euros

for the full year, according to Visible Alpha Consensus.

WPP ( WPP ) is forecast to report revenue less pass-through costs

of 11.4 billion pounds, or 13.7 billion euros, according to a

company-compiled consensus.

(1 euro = 0.8290 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
-- Imperial Metals Brief: Says Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
-- Imperial Metals Brief: Says Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
Aug 6, 2025
03:56 PM EDT, 08/06/2025 (MT Newswires) -- Price: 3.96, Change: +0.01, Percent Change: +0.25 ...
Jazz Pharmaceuticals Says US FDA Granted Accelerated Approval for Modeyso
Jazz Pharmaceuticals Says US FDA Granted Accelerated Approval for Modeyso
Aug 6, 2025
03:52 PM EDT, 08/06/2025 (MT Newswires) -- Jazz Pharmaceuticals ( JAZZ ) said Wednesday that the US Food and Drug Administration granted accelerated approval for Modeyso, or dordaviprone, for the treatment of patients 1 year of age and older with recurrent H3 K27M-mutant diffuse midline glioma, a type of brain tumor. The FDA's decision was based on an integrated efficacy...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
US appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companies
US appeals court reinstates drug-price conspiracy lawsuit against Sanofi, rival pharma companies
Aug 6, 2025
Aug 6 (Reuters) - Drugmakers Sanofi, Eli Lilly ( LLY ), Novo Nordisk and AstraZeneca ( AZN ) must face a lawsuit from two health centers accusing them of conspiring to restrict drug discounts offered to community pharmacies that contract with providers serving low-income patients. A three-judge panel of the 2nd U.S. Circuit Court of Appeals in New York ruled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved